GCA
MD icon

Gideon Capital Advisors’s Pediatrix Medical MD Stock Holding History

Gideon Capital Advisors’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,353
Closed -$203K – 450
2018
Q3 		$203K Buy
+4,353
New +$200K 0.1% 323

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gideon Capital Advisors's MD Position: Q4 2018 in Review

Gideon Capital Advisors sold out of Pediatrix Medical (MD) in Q4 2018, closing a stake of 4,353 shares — an estimated $203K sold.

Gideon Capital Advisors first reported a position in MD in Q3 2018 and held it in 1 quarter. The position peaked at $203K in Q3 2018. 307 funds tracked by Wall St. Rank hold MD as of Q4 2018.

  • Gideon Capital Advisors reported no remaining Pediatrix Medical position as of Q4 2018 after selling out during the quarter.
  • Gideon Capital Advisors sold 4,353 Pediatrix Medical shares in Q4 2018, an estimated $203K.
  • Gideon Capital Advisors first reported a position in Pediatrix Medical in Q3 2018 and held it in 1 quarter.
  • Gideon Capital Advisors's Pediatrix Medical position peaked at $203K in Q3 2018.
  • 307 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2018.

Based on Gideon Capital Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.